| Literature DB >> 27579734 |
Bruna Lavinas Sayed Picciani1, Tábata Alves Domingos1, Thays Teixeira-Souza1, Vanessa de Carla Batista Dos Santos1, Heron Fernando de Sousa Gonzaga2, Juliana Cardoso-Oliveira3, Alexandre Carlos Gripp3, Eliane Pedra Dias1, Sueli Carneiro3.
Abstract
Geographic tongue is a chronic, inflammatory, and immune-mediated oral lesion of unknown etiology. It is characterized by serpiginous white areas around the atrophic mucosa, which alternation between activity, remission and reactivation at various locations gave the names benign migratory glossitis and wandering rash of the tongue. Psoriasis is a chronic inflammatory disease with frequent cutaneous involvement and an immunogenetic basis of great importance in clinical practice. The association between geographic tongue and psoriasis has been demonstrated in various studies, based on observation of its fundamental lesions, microscopic similarity between the two conditions and the presence of a common genetic marker, human leukocyte antigen (HLA) HLA-C*06. The difficulty however in accepting the diagnosis of geographic tongue as oral psoriasis is the fact that not all patients with geographic tongue present psoriasis. Some authors believe that the prevalence of geographic tongue would be much greater if psoriatic patients underwent thorough oral examination. This study aimed to develop a literature review performed between 1980 and 2014, in which consultation of theses, dissertations and selected scientific articles were conducted through search in Scielo and Bireme databases, from Medline and Lilacs sources, relating the common characteristics between geographic tongue and psoriasis. We observed that the frequency of oral lesions is relatively common, but to establish a correct diagnosis of oral psoriasis, immunohistochemical and genetic histopathological analyzes are necessary, thus highlighting the importance of oral examination in psoriatic patients and cutaneous examination in patients with geographic tongue.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27579734 PMCID: PMC4999097 DOI: 10.1590/abd1806-4841.20164288
Source DB: PubMed Journal: An Bras Dermatol ISSN: 0365-0596 Impact factor: 1.896
Figure 1A and B - Clinical association of fissured tongue (black arrow) and geographic tongue (blue arrow) in psoriatic patient
Geographic tongue and fissured tongue prevalence in psoriatic patients and control subjects
| References | Total (n) | Geographic tongue (%) | Fissured tongue (%) | |||||
|---|---|---|---|---|---|---|---|---|
| Psoriasis | Control | Psoriasis | Control | Psoriasis | Control | |||
| Daneshpazhooh | 200 | 200 | 14 | 6 | 33 | 9.5 | ||
| Zargari (2006)[ | 306 | N | 7.2 | N | 9.8 | N | ||
| Hernández-Pérez | 80 | 127 | 12.5 | 4.7 | 47.5 | 20.4 | ||
| Costa | 166 | 166 | 18.1 | 4.2 | 34.3 | 16.2 | ||
| Tomb | 400 | 1000 | 7.7 | 1 | 33.2 | 9.9 | ||
| Picciani | 203 | N | 12.1 | N | 34.4 | N | ||
| Singh | 600 | 800 | 5.6 | 0.8 | 45.3 | 40 | ||
N - It does not present control and analysis of the presence of geographic tongue or fissured tongue
Figure 2Major clinical, histopathological and immunogenetic features found in geographic tongue, showing similarity between GT and psoriasis. Highlighted image of the interaction found in geographic tongue among the CD8 T-lymphocytes, HLA-Cw6 and -B58 and keratinocytes
Figure 3Main histopathological aspects of geographic tongue
Figure 4Immunohistochemical marking aspects of the CD3, CD4 and CD8 cells in patients with geographic tongue with and without psoriatic disease
Class I and II HLA often associated with psoriasis vulgaris (PV) and geographic tongue (GT) in population studies (p <0.05)
| Reference | Country | Sample | Class I HLA (OR) | Class II HLA (OR) | HLA typing methods | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PV | GT | C | PV | GT | PV | GT | |||||
| Marks &Taitt (1980)[ | Australia | - | 95 | - | B15 | - | - | Serological | |||
| Fenerli | Greece | - | 50 | 380 | - | - | - | DR5 (2.2) | Serological | ||
| DRw6 (3.3) | |||||||||||
| Gonzaga | Brazil | 22 | 32 | 159 | Cw6 (10.0) | Cw6 (5.4) | - | - | Serological | ||
| B17 (10.1) | |||||||||||
| B13 (6.8) | B13 (5.7) | ||||||||||
| Enerback | Sweden | 201 | - | 77 | Cw | - | - | - | Molecular | ||
| Kim | Korea | 84 | - | 98 | A1 (17.0) | - | DRB1 | - | Serological | ||
| A30 (5.5) | DRB1 | Molecular | |||||||||
| B13 (5.6) | DQA1 | ||||||||||
| B37 (30.3) | DPB1 | ||||||||||
| Zhang | China | 189 | - | 273 | - | - | DQA1 | - | Molecular | ||
| DQA1 | |||||||||||
| Magalhães | Brazil | 69 | - | 70 | B57 (5.3) | - | DRB1 | - | Molecular | ||
| Cw6 (3.9) | |||||||||||
| Cw12 (3.8) | |||||||||||
| Shawkatová | Slovakia | 147 | - | 194 | C | - | DRB1 | - | Molecular | ||
| DQB1 | |||||||||||
C – Control group;
RR – Relative Risk; OR - odds ratio; Confidence interval 95%
| ( ) Higher expression in the epidermis | |
| ( ) Marked with anti-CD31 antibody | |
| ( ) Predominantly in the dermis | |
| ( ) Nuclear hyperproliferation of cell in basal and parabasal layers |
| Answer key | |||
|---|---|---|---|
| High frequency ultrasound with color
Doppler in Dermatology | |||
| Papers | |||
|---|---|---|---|
| Information for all members:
The EMC-D questionnaire |